Young R F, Bach F W, Van Norman A S, Yaksh T L
Department of Neurological Surgery, University of California Irvine School of Medicine, Orange.
J Neurosurg. 1993 Dec;79(6):816-25. doi: 10.3171/jns.1993.79.6.0816.
The authors systematically studied the release of the endogenous opioid peptides beta-endorphin and methionine (met)-enkephalin into the cerebrospinal fluid (CSF) during deep brain stimulation in patients suffering from otherwise intractable chronic pain. Nine patients were included in the study; six had stimulation electrodes placed in both the periventricular gray matter (PVG) and the thalamic nucleus ventralis posterolateralis (VLP) and three in the PVG only. Immunoreactivity of beta-endorphin and met-enkephalin (beta-EPir and MEir, respectively) was measured by radioimmunoassays in ventricular and lumbar CSF samples obtained before, during, and after stimulation. Prestimulation concentrations of beta-EPir and MEir were lower in ventricular than in lumbar CSF (6.6 +/- 0.5 vs. 13.7 +/- 1.0 pmol/liter, p = 0.0001, for beta-EPir; 33.6 +/- 5.1 vs. 48.3 +/- 3.2 pmol/liter, p < 0.05, for MEir). Ventricular CSF concentrations of both beta-EPir and MEir increased significantly during PVG stimulation, whereas VPL stimulation was without effect. No changes were seen in lumbar CSF levels of the peptides during stimulation in either site. A significant inverse relationship was found between the "during:before stimulation" ratios of visual analog scale ratings and beta-EPir levels during PVG stimulation. The beta-EPir and MEir concentration during:before stimulation ratios were positively correlated, whereas no correlation was present in prestimulation samples from ventricular or lumbar CSF. High-performance liquid chromatography of ventricular CSF pools obtained during PVG stimulation revealed that major portions of beta-EPir and MEir eluted as synthetic beta-endorphin and met-enkephalin, respectively, thus documenting the release of beta-endorphin and met-enkephalin into ventricular CSF during PVG stimulation. The finding of a direct relationship between beta-EPir release and pain alleviation may suggest a role for beta-endorphin in the analgesic mechanism of PVG stimulation.
作者系统地研究了患有其他方法难以治疗的慢性疼痛患者在深部脑刺激过程中内源性阿片肽β-内啡肽和甲硫氨酸(met)-脑啡肽释放到脑脊液(CSF)中的情况。该研究纳入了9名患者;6名患者的刺激电极置于脑室周围灰质(PVG)和丘脑后外侧腹核(VLP),3名患者仅置于PVG。通过放射免疫分析法在刺激前、刺激期间和刺激后采集的脑室和腰段脑脊液样本中测量β-内啡肽和甲硫氨酸-脑啡肽(分别为β-EPir和MEir)的免疫反应性。刺激前,脑室中β-EPir和MEir的浓度低于腰段脑脊液(β-EPir为6.6±0.5对13.7±1.0 pmol/升,p = 0.0001;MEir为33.6±5.1对48.3±3.2 pmol/升,p < 0.05)。在PVG刺激期间,脑室脑脊液中β-EPir和MEir的浓度均显著增加,而VPL刺激则无影响。在两个部位的刺激过程中,腰段脑脊液中这些肽的水平均未发生变化。在PVG刺激期间,视觉模拟量表评分的“刺激期间:刺激前”比值与β-EPir水平之间发现显著的负相关关系。β-EPir和MEir浓度的刺激期间:刺激前比值呈正相关,而在脑室或腰段脑脊液的刺激前样本中不存在相关性。对PVG刺激期间采集的脑室脑脊液池进行高效液相色谱分析显示,β-EPir和MEir的主要部分分别以合成的β-内啡肽和甲硫氨酸-脑啡肽形式洗脱,从而证明在PVG刺激期间β-内啡肽和甲硫氨酸-脑啡肽释放到脑室脑脊液中。β-EPir释放与疼痛缓解之间存在直接关系这一发现可能表明β-内啡肽在PVG刺激的镇痛机制中发挥作用。